Doctors polled on inflammation blood test for heart and kidney patients

NCT ID NCT07160829

Completed Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study surveyed 608 heart and kidney doctors to understand their awareness and use of a blood test called hsCRP, which measures inflammation. The goal was to learn what doctors think about inflammation's role in treating patients with heart disease, kidney disease, or heart failure. No treatments were given—only opinions were collected through an online questionnaire.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis atherosclerotic cardiovascular disease chronic kidney disease chronic renal failure syndrome heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE CHRONIC KIDNEY DISEASE HEART FAILURE

Contacts and locations

Show contact details

Locations

Novo Nordisk Investigational Site

Sydney, 2060, Australia
Novo Nordisk Investigational Site

Bangalore, Karnataka, India
Novo Nordisk Investigational Site

Seoul, South Korea
Novo Nordisk Investigational Site

Bangkok, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.